학술논문

Acute ischaemic stroke associated with SARS-CoV-2 infection in North America
Document Type
article
Source
Journal of Neurology Neurosurgery & Psychiatry. 93(4)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Stroke
Clinical Research
Neurosciences
Good Health and Well Being
Brain Ischemia
COVID-19
Humans
Ischemic Stroke
Middle Aged
Retrospective Studies
SARS-CoV-2
Thrombectomy
Treatment Outcome
stroke
interventional
North American Neurovascular COVID-19 (NAN-C) Consortium & Society of Vascular and Interventional Neurology (SVIN) Investigators
Medical and Health Sciences
Psychology and Cognitive Sciences
Neurology & Neurosurgery
Clinical sciences
Language
Abstract
BackgroundTo analyse the clinical characteristics of COVID-19 with acute ischaemic stroke (AIS) and identify factors predicting functional outcome.MethodsMulticentre retrospective cohort study of COVID-19 patients with AIS who presented to 30 stroke centres in the USA and Canada between 14 March and 30 August 2020. The primary endpoint was poor functional outcome, defined as a modified Rankin Scale (mRS) of 5 or 6 at discharge. Secondary endpoints include favourable outcome (mRS ≤2) and mortality at discharge, ordinal mRS (shift analysis), symptomatic intracranial haemorrhage (sICH) and occurrence of in-hospital complications.ResultsA total of 216 COVID-19 patients with AIS were included. 68.1% (147/216) were older than 60 years, while 31.9% (69/216) were younger. Median [IQR] National Institutes of Health Stroke Scale (NIHSS) at presentation was 12.5 (15.8), and 44.2% (87/197) presented with large vessel occlusion (LVO). Approximately 51.3% (98/191) of the patients had poor outcomes with an observed mortality rate of 39.1% (81/207). Age >60 years (aOR: 5.11, 95% CI 2.08 to 12.56, p